SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

Piper Sandler Maintains Overweight on Stryker, Raises Price Target to $260

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $250 to $260.

Benzinga · 09/14/2022 07:39
Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $250 to $260.